調査レポート | • レポートコード：QYR2104Z2521 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、卵巣がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、腫瘍内、腹腔内）、用途別市場規模（卵巣がん（詳細不明）、再発卵巣上皮がん、プラチナ耐性卵巣がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・卵巣がん遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・卵巣がん遺伝子治療の種類別市場規模（静脈内、腫瘍内、腹腔内） ・卵巣がん遺伝子治療の用途別市場規模（卵巣がん（詳細不明）、再発卵巣上皮がん、プラチナ耐性卵巣がん） ・卵巣がん遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・卵巣がん遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・卵巣がん遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・卵巣がん遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・卵巣がん遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takara Bio、VBL Therapeutics、CELSION、Targovax） ・結論 |
Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.
Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.
Market Analysis and Insights: Global Gene Therapy for Ovarian Cancer Market
The global Gene Therapy for Ovarian Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy for Ovarian Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy for Ovarian Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy for Ovarian Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy for Ovarian Cancer market.
Global Gene Therapy for Ovarian Cancer Scope and Market Size
Gene Therapy for Ovarian Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intravenous
Intratumoral
Intraperitoneal
Segment by Application
Ovarian Cancer (unspecified)
Recurrent Ovarian Epithelial Cancer
Platinum-Resistant Ovarian Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takara Bio
VBL Therapeutics
CELSION
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Intratumoral
1.2.4 Intraperitoneal
1.3 Market by Application
1.3.1 Global Gene Therapy for Ovarian Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ovarian Cancer (unspecified)
1.3.3 Recurrent Ovarian Epithelial Cancer
1.3.4 Platinum-Resistant Ovarian Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2016-2027)
2.2 Gene Therapy for Ovarian Cancer Growth Trends by Regions
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy for Ovarian Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy for Ovarian Cancer Industry Dynamic
2.3.1 Gene Therapy for Ovarian Cancer Market Trends
2.3.2 Gene Therapy for Ovarian Cancer Market Drivers
2.3.3 Gene Therapy for Ovarian Cancer Market Challenges
2.3.4 Gene Therapy for Ovarian Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue
3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue
3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio
3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2020
3.5 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
3.7 Date of Enter into Gene Therapy for Ovarian Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Ovarian Cancer Breakdown Data by Type
4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2022-2027)
5 Gene Therapy for Ovarian Cancer Breakdown Data by Application
5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy for Ovarian Cancer Market Size (2016-2027)
6.2 North America Gene Therapy for Ovarian Cancer Market Size by Type
6.2.1 North America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2027)
6.3 North America Gene Therapy for Ovarian Cancer Market Size by Application
6.3.1 North America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2027)
6.4 North America Gene Therapy for Ovarian Cancer Market Size by Country
6.4.1 North America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2016-2027)
7.2 Europe Gene Therapy for Ovarian Cancer Market Size by Type
7.2.1 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2016-2027)
7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Application
7.3.1 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2016-2027)
7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Country
7.4.1 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type
8.2.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application
8.3.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region
8.4.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy for Ovarian Cancer Market Size (2016-2027)
9.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Type
9.2.1 Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Application
9.3.1 Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy for Ovarian Cancer Market Size by Country
9.4.1 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type
10.2.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application
10.3.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country
10.4.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Details
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction
11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021)
11.1.5 Takara Bio Recent Development
11.2 VBL Therapeutics
11.2.1 VBL Therapeutics Company Details
11.2.2 VBL Therapeutics Business Overview
11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction
11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021)
11.2.5 VBL Therapeutics Recent Development
11.3 CELSION
11.3.1 CELSION Company Details
11.3.2 CELSION Business Overview
11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction
11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021)
11.3.5 CELSION Recent Development
11.4 Targovax
11.4.1 Targovax Company Details
11.4.2 Targovax Business Overview
11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction
11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021)
11.4.5 Targovax Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Intratumoral
Table 4. Key Players of Intraperitoneal
Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2016-2021)
Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2022-2027)
Table 11. Gene Therapy for Ovarian Cancer Market Trends
Table 12. Gene Therapy for Ovarian Cancer Market Drivers
Table 13. Gene Therapy for Ovarian Cancer Market Challenges
Table 14. Gene Therapy for Ovarian Cancer Market Restraints
Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2016-2021)
Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2020)
Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
Table 22. Date of Enter into Gene Therapy for Ovarian Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takara Bio Company Details
Table 63. Takara Bio Business Overview
Table 64. Takara Bio Gene Therapy for Ovarian Cancer Product
Table 65. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 66. Takara Bio Recent Development
Table 67. VBL Therapeutics Company Details
Table 68. VBL Therapeutics Business Overview
Table 69. VBL Therapeutics Gene Therapy for Ovarian Cancer Product
Table 70. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 71. VBL Therapeutics Recent Development
Table 72. CELSION Company Details
Table 73. CELSION Business Overview
Table 74. CELSION Gene Therapy for Ovarian Cancer Product
Table 75. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 76. CELSION Recent Development
Table 77. Targovax Company Details
Table 78. Targovax Business Overview
Table 79. Targovax Gene Therapy for Ovarian Cancer Product
Table 80. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 81. Targovax Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Intratumoral Features
Figure 4. Intraperitoneal Features
Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2027
Figure 6. Ovarian Cancer (unspecified) Case Studies
Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies
Figure 8. Platinum-Resistant Ovarian Cancer Case Studies
Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered
Figure 10. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2022-2027)
Figure 14. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2020
Figure 15. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2020
Figure 17. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 21. North America Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 22. North America Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 23. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 27. Europe Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 28. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 29. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2016-2027)
Figure 39. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 59. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 60. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 61. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
世界の卵巣がん市場規模・現状・予測（2021年-2027年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …- 世界の卵巣がん治療薬市場規模・現状・予測（2021年-2027年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…
- 世界の卵巣がん診断＆治療市場規模・現状・予測（2021年-2027年） Ovarian cancer is often fatal because it is usually advanced when diagnosed. Symptoms are usually absent in early stages and nonspecific in advanced stages.The goal of treatment for ovarian cancer is to surgically remove as much of the cancer as possible through the debulking and then to provide wha…
- 世界の卵巣がん診断市場規模・現状・予測（2021年-2027年） Electroceramics are advanced ceramic materials that exhibit electronic, optical or electro-magnetic properties. Electroceramic materials are used for specific technological applications, which include the manufacture of data storage devices, sensors, transducers, and actuators. Electroceramic materi…
- 世界の卵巣がん診断市場規模・現状・予測（2021年-2027年） Electroceramics are advanced ceramic materials that exhibit electronic, optical or electro-magnetic properties. Electroceramic materials are used for specific technological applications, which include the manufacture of data storage devices, sensors, transducers, and actuators. Electroceramic materi…